(Q45383108)

English

Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

scientific article published in August 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus (English)

1 reference

Europe PubMed Central

14 December 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

Hepatitis C virus

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

Juan Berenguer

1

1 reference

Europe PubMed Central

14 December 2017

Julio Alvarez-Pellicer

2

1 reference

Europe PubMed Central

14 December 2017

Pilar Miralles Martín

3

1 reference

Europe PubMed Central

14 December 2017

José López-Aldeguer

4

1 reference

Europe PubMed Central

14 December 2017

Miguel Angel Von-Wichmann

5

1 reference

Europe PubMed Central

14 December 2017

Carmen Quereda

6

1 reference

Europe PubMed Central

14 December 2017

Josep Mallolas

7

1 reference

Europe PubMed Central

14 December 2017

José Sanz

8

1 reference

Europe PubMed Central

14 December 2017

Cristina Tural

9

1 reference

Europe PubMed Central

14 December 2017

José María Bellón

10

1 reference

Europe PubMed Central

14 December 2017

Juan González-García

11

1 reference

Europe PubMed Central

14 December 2017

GESIDA3603/5607 Study Group

12

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 August 2009

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

50

1 reference

Europe PubMed Central

14 December 2017

2

1 reference

Europe PubMed Central

14 December 2017

407-413

1 reference

Europe PubMed Central

14 December 2017

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

The progression of HCV-associated liver disease in a cohort of haemophilic patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

The natural history of hepatitis C with severe hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

21 January 2018

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23020

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23020

1 reference

Europe PubMed Central

14 December 2017

release_r7xzpdtl2rgkjakxuqbc7ch62y

1 reference

https://api.fatcat.wiki/v0/release/r7xzpdtl2rgkjakxuqbc7ch62y

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

14 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45383108&oldid=2076283118"